ObjectivesTo explore how formative OSCEs influence student performance and perception when
undertaking summative OSCEs.MethodsWe introduced formative OSCEs for second-year medical students at a large London
medical school. Examination data from both formative and subsequent summative
OSCEs were analysed to determine the effect on summative OSCE performance. We
gathered student perceptions using an anonymous online survey tool. The data was
investigated using a standard scale of 1 to 5 and qualitative analysis of free
text.ResultsOverall, 46.6% and 85.0% of students passed the formative and summative OSCEs
respectively. Formative OSCEs did not improve overall pass rates in summative
OSCEs. Inclusion of an individual formative station was associated with improved
performance in that station in summative OSCEs, with one exception. Formative
OSCEs had a positive predictive value of 92.5% for passing the summative OSCE
but limited negative predictive value. Students who passed fewer than two out of
three formative OSCE stations were significantly more likely to fail the
summative OSCE (78.2% vs 89.7%, p <0.001). Students felt formative OSCEs were
good exam preparation and suggested logistical changes.Conclusion Formative OSCEs were associated with improved performance in subsequent
summative OSCEs only for identical stations. They did not improve overall pass
rates in summative OSCEs, and did not predict performance well. Students viewed
the formative OSCE as a positive and useful activity. However, to maximise its
benefit as a tool for learning, students need better communication about the
role and purpose of formative OSCEs.
ObjectivesThere is a lack of evidence regarding the effectiveness of graphic health warning labels (GHWL) in different individuals, including patients with chronic obstructive pulmonary disease (COPD). Investigating knowledge and attitudes may allow better implementation of future public health policies. We hypothesised that differences in the impact of GHWL exist between non-smokers, smokers and patients with COPD, with decreased efficacy in those groups who are longer and more frequently exposed to them.Participants and setting163 participants (54% male, aged 21–80) including 60 non-smokers, 53 smokers and 50 patients with COPD (Gold stage II–IV), attending London respiratory outpatient clinics, participated in case-controlled surveys (50 items).Outcome measuresTen different GHWL were shown and demographics, smoking history, plans to quit, smoking-risk awareness, emotional response, processing and impact of GHWL on behaviour were recorded. Patients were further asked to prioritise the hypothetical treatment or prevention of five specific smoking-related diseases.ResultsSmokers, in particular those with COPD, were less susceptible to GHWL than non-smokers; 53.4% of all participants expressed fear when looking at GHWL, non-smokers (71.9%) more so than smokers (39.8%, p<0.001). COPD participants were less aware of the consequences than non-COPD participants (p<0.001), including an awareness of lung cancer (p=0.001). Lung cancer (95%), oral cancer (90.2%), heart disease (84.7%) and stroke (71.2%) were correctly associated with smoking, whereas blindness was least associated (23.9%). However, blindness was prioritised over oral cancer, stroke and in patients with COPD also over heart disease when participants were asked about hypothetical treatment or prevention.ConclusionsGHWL are most effective in non-smokers and a desensitisation effect was observed in smokers and patients with COPD. As a consequence, a tailored and concerted public health approach to use such messages is required and ‘blindness’ deserves to be mentioned in this context because of an unexpectedly high-deterring impact.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.